Currently Enrolling Research Studies
“People with Diabetes Mellitus live each day in their own clinical study, as subject and investigator, generating the data that leads to their well-being”
-James Field MD, Endocrinologist
Currently Enrolling Studies at University Diabetes & Endocrine Research Center
- At least 18 years of age
- Have Type II Diabetes > 90 days
- Taking oral meds or insulin or both AND
- have A cardiac condition AND/OR
- have Increased lipids AND/OR
- have diabetic retinopathy AND/OR
- have chronic kidney disease
for Persons within 72 hours of COVID-19 symptoms and/or positive RNA test.
Monoclonal Antibody Infusion Study
Offers 1 hour infusion of spike protein antibodies to bind and dispose of COVID-19 virus. This study is placebo controlled. For all participants, Laboratory monitoring of COVID allows your doctor to prevent and treat any COVID complications.
Patients with Nonalcoholic Steatohepatitis
If you have fatty liver with elevated liver function tests
OR cirrhosis with portal hypertension
you may qualify for studies which will define the stage and severity of liver problems and test medicines to improve liver function